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LABORATORY INVESTIGATION
Elimination of Candida albicans from kidneys of mice during
short-term systemic infections
ABOLGHASEM BAGHIAN and KENNETH W. LEE
Department of Botany and Microbiology, Arizona State University, Tempe, Arizona, USA
Elimination of Candida albicans from kidneys of mice during short-
term systemic infections. The candidacidal activity of kidneys, liver, and
spleen's phagocytic systems was studied in mouse. Different strains of
mice were inoculated intravenously (i.v.) with I to 2.6 X l0 viable
Candida albicans. Elimination of the microorganisms from the kidneys,
liver, and spleen were evaluated by enumeration of colony forming
units (C.F.U.) recovered from homogenates of organs dissected within
a short period of time (0 to 5 hr). The results indicated that the kidneys
possess a capable phagocytic system which was able to eliminate the
microorganisms as efficiently as those of liver and spleen. Furthermore,
the ability of the liver and spleen phagocytic system as well as that of
kidneys were significantly enhanced when animals were treated with
Bacillus Calmette-Guerin (BCG) of mycobacterium bovis four weeks
prior to induction of systemic infection with C. albicans.
Candida albicans remains one of the organisms most fre-
quently producing infection in the compromised host [1, 2]. In
the normal individuals, it has become apparent that a formida-
ble barrier to C. albicans is provided by a multitude of effector
and control mechanisms [3—16]. Yet, clearly defined experimen-
tal evidence for the precise mechanism(s) of resistance, either
innate or acquired, to candidosis is lacking. Antibodies [15, 17,
181 and other serum factors [14, 19], T-lymphocytes [1—3, 8, 11,
13, 15, 16] and phagocytes [3, 4, 7, 10, 12, 13, 20] all have been
implicated in resistance to Candida infection. However, the
individual contribution(s) of each of these resistance factors is
not well defined.
In the majority of experimentally-induced systemic infections
in different conventional strains of mice, the kidneys of animals
were the organ that bore the heaviest foci of infections through-
out the experiments [3, 4, 6, 9, 11, 16]. By contrast, the liver
and spleen, even in T cell deficient nude mice, were capable of
clearing the candida infections [11, 16]. Recently, we reported
that in the beige mouse, a murine model of human Chediak-
Higashi syndrome (CHS), the liver and spleen of the animal
were unable to clear the infection and remained infected
throughout the trial [3, 4]. Since the beige mouse was shown to
have a defective immune system, including abnormal polymor-
phonuclear leukocytes (PMNs) [21], we proposed an important
role for these cells in fighting systemic candidosis. We further
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suggested that in the absence of normally functioning PMNs,
activated macrophages play a decisive role in removing the
microorganisms from the liver and spleen of the beige mouse
[31. It is unclear why kidneys are so much more susceptible to
candida infections. Even in the BCG treated beige mouse,
where the liver and spleen, due to activation of macrophages,
were able to clear the candida infections, the kidneys still
remained heavily infected [31.
It has been shown that mesangial cells have several macro-
phage activities. They exhibit phagocytic activities and produce
interleukin-l and lysosomal enzymes [22—25]. These macro-
phage-like properties make the mesangial cell a potential can-
didate to act as renal resident macrophage.
This study was initiated to investigate the early events of the
experimentally induced systemic candidosis in terms of the role
of phagocytes in clearing microorganisms during one to five
hours post-infection, from kidneys, liver and spleen of different
strains of mice.
Methods
Microorganism
Candida albicans strain B3 11 (type A), originally obtained
from H.F. Hasenclever, National Institutes of Health (Be-
thesda, Maryland, USA), has been maintained in our laboratory
by monthly transfers on Sabouraud dextrose agar (SDA) slants.
Yeast cells were cultured for 24 hours at 37°C on SDA then
stored at 4°C. For experiments, a single stock was prepared
with organisms that were grown on SDA for 24 hours at 37°C,
washed from the slants, and stored at —70°C in 1 to 2 ml of
sterile saline at a concentration of 1 x 108 viable units per ml.
The standard i.v. challenge used in this study was 1 x io viable
units in 0.25 ml of phosphate-buffered saline (PBS) injected into
a lateral tail vein.
The morphology and biochemical characteristics of C. albi-
cans were verified by microscopic observations, colonial mor-
phology on SDA, formation of germ tubes in serum, formation
of chlamydospores on chlamydospore agar, and sugar fermen-
tation reactions.
Mycobacterium bovis strain GL2 (BCG) was a gift from
Jacqueline Vanderwinkel, Pasteur Institute, Brussels, Belgium,
and was maintained at —70°C in 0.85% saline solution contain-
ing 0.1% gelatin [20]. Mice were injected i.v. with a single dose
containing approximately 5 x iO BCG in 0.25 ml saline four
weeks before challenge with C. albicans. Experiments with
Listeria monocytogenes (3 x l0, i.v.) served as the control to
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substantiate that our BCG treatment protocol resulted in en-
hanced macrophage function. The number of L. monocyto-
genes cultured from the spleens and livers of BCG-treated mice
was 1,000- to 10,000-fold less than cultured from the respective
organs of PBS-treated control mice.
L. monocytogenes was provided by Dr. Edward Balish,
Department of Surgery, University of Wisconsin, Madison. The
organism was grown on 5% sheep blood agar at 37°C for 48
hours, collected in saline, and washed by centrifugation. Or-
ganisms were resuspended in the gelatin solution as described
above and frozen at —70°C [20].
Mice
Congenitally athymic (nude) BALB/c mice and their thymus-
bearing phenotypically NLMs were produced by mating ho-
mozygous (nu/nu) males with heterozygous (nu/+) females.
Nude and nu/+ mice were bred and housed in Bioclean Porta-
Room containment units (Hazleton Systems, Inc., Aberdeen,
Maryland, USA) and were offered food and acidified-chlori-
nated water ad libitum. The lack of a thymus was confirmed in
each mouse at necropsy. Groups of nude mice were periodically
assessed for their ability to reject allogenic or xenogeneic skin
grafts and to form antibodies to a thymus-dependent antigen,
sheep erythrocytes.
Beige mice and their phenotypically NLMs (bg/+) on a
C57BL16 background were produced by mating the appropriate
homozygous (bglbg) and heterozygous (bg/+) animals.
C57BL16 mice were maintained under conventional housing
conditions and were offered food and water ad libitum. Swiss-
Webster mice were produced by random mating and maintained
as were C57BL/6 mice.
Calculation of candidacidal activities ofphagocytic systems
of the organs
Percent killing of C. albicans by phagocytes was calculated
as follows:
Percent killing
=
cfu recovered at "0" hour — cfu recovered at a point of time x 100
cfu recovered at '0" hour
Results
Recovery of C. albicans from kidneys, liver, and spleen of
different strains of mice during short-term systemic
candidosis
Results presented in Figures 1 and 2 display cfu recovered
from the kidneys, livers, and spleens of different strains of mice
following intravenous inoculation with 1 x io viable organ-
isms. Results of these two separate experiments revealed that
the three organs of all strains of mice cleared a significant
number of the inoculated organisms during five hours of infec-
tion. The phagocytic system of kidneys, in particular, showed
distinct efficiency in eliminating C. albicans during this short
period (Figs. 1 and 2).
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Fig. 1. Recove,y of C. albicans (cfu) from
organs of different strains of mice following
i.v. inoculation of! x 1O viable organisms.
Symbols are: ( ) livers; (0) kidneys; (
spleens. The results report the number of cfu
obtained by pooling corresponding organs
from 3 to 5 mice. (A) Beige mouse; (B) Beige
normal littermate; (C) BALB/c mouse; (D)
BALB/c nude mouse; (E) Swiss Webster
mouse.
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Fig. 2. Recovery of C. albicans (cfu) from organs of
different strains of mice following i. v. inoculation of I x
1O viable organisms. Symbols are: ( 0 ) livers; (0)
kidneys; ( ) spleens. The results report the cfu
obtained by pooling corresponding organs from 3 to 5
mice. (A) Beige mouse; (B) Beige normal littermate; (C)
BALB/c mouse; (D) BALB/c nude mouse.
Recovery of C. albicans from kidneys, liver, and spleen of
animals treated with BCG
In experiments 3 and 4, when PBS and BCG treated mice
were intravenously inoculated with 1 x iO (Fig. 3) and 2.6 x
iø (Fig. 4) viable C. albicans the three organs of different
strains of mice cleared a significant number of the organisms
during a five hours period of infection. The phagocytic system
of PBS treated mice demonstrated activity similar to the obser-
vations obtained from experiments 1 and 2 (Figs. 1 and 2) in
clearing the organism from these organs. However, phagocytic
systems of the organs of animals treated with BCG showed
more candjdacjdal activities than those of PBS treated animals.
This activity was more obvious in the kidneys and spleen at five
hours post-infection (Figs. 3 and 4). This ability was uncompro-
mised when the number of inoculated organisms was increased
over 2.5-fold (Fig. 4).
Percent killing by phagocytic systems of kidneys, liver, and
spleen
Tables 1 to 4 demonstrate the percent killing of C. albicans,
by the phagocytic systems of these organs. The percent of
killing were calculated from the results of these four experi-
ments.
Discussion
Renal burden of C. albicans during systemically-induced
candida infections in all strains of mice studied remained high
[3, 4, 6, 9, 11, 16]. It has been suggested that the physiological
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Fig. 3. Recovery of C. albicans (cfu) from organs of
djfferent strains of mice treated with PBS or BCG. Mice
were inoculated i.v. with I x iO viable organisms four
weeks after BCG treatment. Symbols are: ( 0 ) livers
PBS; 0) livers BCG; ( 0 ) kidneys PBS; ( ) kidneys
BCG; ) spleens PBS; ( I spleens BCG. The results
report the cfu obtained by pooling corresponding organs
from 3 to 5 mice. (A) Beige mouse; (B) Beige normal
littermate; (C) Swiss-Webster mouse.
Fig. 4. Recovery of C. albicans (cfu) from organs of
mice treated with PBS and BCG. Symbols are: ( 0
livers PBS; (0) livers BCG; ( 0 ) kidneys PBS; ( 0
kidneys BCG; ( I spleens PBS; ( ) spleens BCG.
Mice were inoculated i.v. with 2.6 x lO viable
organisms four weeks after BCG treatment. Each
number is the cfu obtained by pooling corresponding
organs from 3 to 5 mice. (A) Beige mouse; (B) Beige
normal littermate.
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conditions [26—28] and the poor phagocytic system of kidneys
[29] are contributing factors for predisposition of kidneys to the
long-term systemic candida infections.
Based on our observations and those of others, we suggest
that perhaps anatomical architecture and physiological condi-
tions of kidneys contribute to their susceptibility to candida
infections. We assume that a few yeasts may escape the renal
phagocytic system and reside in regions such as the renal
medulla or tubular area [26, 28] where, due to increased
osmolarity and high content of urea and ammonia, the phago-
cytic and chemotactic activities of recruited PMNs and mono-
cytes are reduced [29, 27]. The delay in inflammatory response
reported by Louria, Brayton and Finkel [26] certainly helps the
yeasts develop pseudohyphae, penetrate the tubular area [26,
28] and produce foci of infection.
It has been shown that pretreatment of mice with BCG or its
analogues induces activation of macrophages [30, 31]. We
presumed that if elimination of C. albicans from organs of
PBS-treated mice is mainly due to activities of phagocytic
systems therefore, treatment of animals with BCG prior to
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Table 1. Candidacidal activities (percent)
Hours post-infection
Kidneys Liver Spleen
Mouse strains 1 5 1 5 1 5
Beige
Beige NLM
BALB/c
BALB/c nude
Swiss-Webster
62 86
66 79
62 94
65 89
60 86
7 54 53
33 66 61
25 79 60
68 75 54
59 84 32
62
78
71
53
69
Percent candidacidal activity of phagocytes calculated from results
presented in Figure 1.
Table 2. Candidacidal activities (percent)
Hours post-infection
Kidneys Liver Spleen
Mouse strains 1 5 1 5 1 5
Beige
Beige NLM
BALB/c
BALB/c nude
58 59
25 83
67 94
80 96
24 66 35
23 66 28
0 82 15
62 74 21
34
49
45
26
Percent candidacidal activity of phagocytes calculated from results
presented in Figure 2.
candida infection should enhance these activities. The results
presented in Figures 3 and 4 as well as Tables 3 and 4 indicated
that this is the case. Treatment of the animals with the BCG
enhanced clearing capabilities of the three organs significantly.
Therefore, we suggest the enhanced candidacidal activities of
the organs from BCG-treated animals within this short period of
time is due to activation of phagocytic systems. These results
also argue against a possible role of physiological clearing of
microorganisms through endocytosis or renal lymphatics. In
fact, the number of organisms recovered from organs of BCG
treated animals at time "0" was far below the number of
organisms recovered from corresponding organs of control
animals treated with PBS, This discrepancy is due to 40 to 60
minutes processing steps during which organs had to be re-
moved and weighed before being homogenized and plated. It
was during this period that activated macrophages with in-
creased bactericidal capabilities acted more efficiently than
macrophages of PBS-treated animals. For this reason the per-
cent killing activities of BCG-treated animals were also calcu-
lated by using cfu recovered from the organs of PBS treated
animals at "0" hours (shown in parentheses, Tables 3 and 4).
The percent of killing presented in parentheses is a more
accurate representative of candidacidal activities of phagocytes
of the organs from BCG-treated animals. Activation of the
phagocytic systems by BCG was more obvious when treated
animals were inoculated with an over 2.5-fold higher number
viable C. albicans (Fig. 4, Table 4).
We should also mention that hepatic and splenic predisposi-
tion of beige mice to candida infection reported previously [3, 4]
is an effect which is observed in the long-term infections. The
results of short-term candida infections do not show such an
inclination. Reasons for this discrepancy are not yet clear.
However, we suggest that hepatic and splenic predisposition to
long-term systemic candida infections in beige mice could be
Table 3. Candidacidal activities (percent)
Hours post-infection
Kidneys Liver Spleen
Mouse strains I 5 1 5 1 5
Beige (PBS)
Beige (BCG)
Beige NLM (PBS)
Beige NLM (BCG)
Swiss-Webster
(PBS)
Swiss-Webster
(BCG)
65 88 21 50 45 44
47 (84) 88 (96) 27 (67) 75 (89) 38 (93) 74 (97)
75 91 26 77 21 53
0 (89) 44 (95) 50 (72) 89 (94) 17 (89) 63 (95)
65 86 65 87 39 67
65 (84) 98 (99) 73 (88) 96 (98) 27 (87) 92 (99)
Percent candidacidal activity of phagocytes calculated from results
presented in Figure 3. Numbers in the parentheses are representatives
of killing activities of organs of BCG-treated animals when cfu recov-
ered from corresponding organs of PBS-treated animals at "0" hours
for corresponding strain of mouse is taken into the account,
Table 4. Candidacidal activities (percent)
Mouse
Hours post-infection
Kidneys Liver Spleen
strains I 5 1 5 1 5
Beige (PBS) 55 88 0 39 57 64
Beige (BCG) 62 (91) 89 (97) 32 (64) 71(84) 56 (79) 93 (96)
Beige NLM 47 88 21 67 20 43
(PBS)
Beige NLM 85 (95) 95 (98) 51(76) 96 (98) 56 (87) 92 (98)
(BCG)
Percent candidacidal activity of phagocytes calculated from results
presented in Figure 4. Numbers in parentheses are representatives of
killing activities of organs of BCG-treated animals when cfu recovered
from corresponding organs of PBS-treated animals at "0" hours for
corresponding strain of mouse is taken into the account.
due to recruitment of premature monocytes and PMNs from
bone marrow. These cells contain greater numbers of abnormal
giant lysosomes [321 which are defective in phagosome-lyso-
some fusion process [32]. This step is an essential phase in
bactericidal activities of phagocytes. Therefore, when these
abnormal phagocytes are recruited to the area of infection they
are unable to combat the microorganism effectively. This situ-
ation provides an opportunity for the yeast to grow and produce
infectious foci in liver and spleen.
Early investigators used the nude mouse in systemically
induced candida infections, and they have questioned the
involvement and importance of CMI in systemic candidosis [6,
11, 161. Nude mouse organs cleared the candida infections
during the short-term systemic infections as efficient as those of
their normal litter mates. These results support the previous
findings.
Our results demonstrated that in contrast to previous conclu-
sions, kidneys possess a strong phagocytic system, and BCG
treatment of animals potentiates this system. Our result also
suggested that the phagocytic system is a crucial defense line
against systemically-induced candida infections.
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